SCHEMBL22960955

SCHEMBL22960955

CCCNC(C)C(C)CC

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.34
HTR2A P28223 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31008662 0.88 LMNA (0.38)
SCHEMBL20808157 0.84 TSHR (0.36) SIGMAR1
SCHEMBL27342613 0.84 SIGMAR1 (0.32) SIGMAR1
SCHEMBL19846890 0.82 SIGMAR1 (0.39) SIGMAR1
SCHEMBL24709931 0.81 SIGMAR1 (0.33) SIGMAR1
SCHEMBL26033641 0.81 SIGMAR1 (0.33) SIGMAR1
SCHEMBL13933200 0.81 LMNA (0.33)
SCHEMBL21799660 0.79 MEN1 (0.30)
SCHEMBL15343474 0.79
SCHEMBL7964907 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230010262-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-12 US disclosed
WO-2021026451-A1 COMPOUNDS AND METHOD FOR TREATING CYTOKINE RELEASE SYNDROME RIGEL PHARMACEUTICALS, INC. (US) 2021-02-11 WO disclosed